Cargando…
Process development and scale-up optimization of the SARS-CoV-2 receptor binding domain–based vaccine candidate, RBD219-N1C1
ABSTRACT: A SARS-CoV-2 RBD219-N1C1 (RBD219-N1C1) recombinant protein antigen formulated on Alhydrogel® has recently been shown to elicit a robust neutralizing antibody response against SARS-CoV-2 pseudovirus in mice. The antigen has been produced under current good manufacturing practices (cGMPs) an...
Autores principales: | Lee, Jungsoon, Liu, Zhuyun, Chen, Wen-Hsiang, Wei, Junfei, Kundu, Rakhi, Adhikari, Rakesh, Rivera, Joanne Altieri, Gillespie, Portia M., Strych, Ulrich, Zhan, Bin, Hotez, Peter J., Bottazzi, Maria Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102132/ https://www.ncbi.nlm.nih.gov/pubmed/33959781 http://dx.doi.org/10.1007/s00253-021-11281-3 |
Ejemplares similares
-
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice
por: Pollet, Jeroen, et al.
Publicado: (2021) -
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2022) -
Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate
por: Chen, Wen-Hsiang, et al.
Publicado: (2021) -
A Recombinant Protein XBB.1.5 RBD/Alum/CpG Vaccine Elicits High Neutralizing Antibody Titers against Omicron Subvariants of SARS-CoV-2
por: Thimmiraju, Syamala Rani, et al.
Publicado: (2023) -
Effects of hot water spray and sub-zero saline chilling on bacterial decontamination of broiler carcasses
por: Kang, I., et al.
Publicado: (2022)